Disrupted Healthcare – 26 Deals and Investments This Week

VC Deals (16 Deals, $380M)

Axonics Modulation Technologies Inc., an Irvine, Calif.-based maker of miniaturized implantable sacral neuromodulation technology, has raised $38.5 million in Series B funding. Edmond de Rothschild Investment Partners Advent Life Sciences and Cormorant Asset Management were joined by return backers Edmond de Rothschild Investment Partners, NeoMed Management, Legend Capital and The Alfred E. Mann Foundation

Gelesis, a Boston-based developer of therapies for weight loss and glycemic control in overweight and obese patients, has raised $31.5 million in new growth equity funding. Cormorant Asset Management was joined by return backers Invesco Asset Management, PureTech Ventures and the Priztker/Vlock Family Office. Gelesis recently withdrew IPO registration

Aquinnah Pharmaceuticals, a Cambridge, Mass.-based drug startup focused on ALS and other neurodegenerative diseases, has raised $5 million in funding from Takeda Pharmaceutical Co

Neural Analytics Inc., a Los Angeles-based developer of devices and services to measure, diagnose and track brain health, has raised $10 million in Series A funding from JSR Ltd. and Taiyu Capital

Dermapharm, a German generic drugmaker, has received first-round takeover bids from at least five private equity firms, according to Reuters. The deal could generate upwards of €1 billion for the company’s selling founder, with suitors reported to include Advent International, Cinven, Carlyle Group, BC Partners and Nordic Capital

Dominus Capital has acquired Complete Nutrition, an Omaha, Neb.-based distributor of nutritional supplements and franchisor of health-focused retail stores. No financial terms were disclosed, except that Monroe Capital arranged a $25.1 million senior credit facility to support the acquisition

Pague Menos Pharmacies, Brazil’s third-largest drugstore retail chain, has secured approximately US$151 million in growth equity funding from General Atlantic. The company expects to generate around $1.25 billion in revenue this year

Effector Therapeutics, a San Diego-based developer of translation regulators for the treatment of cancer, has raised $40 million in Series B funding. Altitude Life Science Ventures led the round, and was joined by AbbVie Biotech Ventures, BioMed Ventures and return bakers Abingworth, Novartis Venture Fund, SR One, The Column Group, US Venture Partners, Astellas Ventures, Osage University Partners and Mission Bay Capital

InnFocus Inc., a Miami, Fla.-based developer of a glaucoma drainage system, has raised $33.9 million in Series C funding. No investor information was disclosed

 Cohero Health, a New York-based developer of connected health technologies for respiratory patients, has raised $2 million in seed funding. Backers include Zaffre Investments, Blue Cross Blue Shield of Massachusetts, Three Leaf Ventures, Bioadvance and Swanhill Capital

Altruista Health Inc., a Reston, Va.-based provider of population health management technology solutions for health plans and healthcare providers, has secured an undisclosed amount of funding from Capricorn Healthcare & Special Opportunities

Assurex Health, a nine-year-old, Mason, Oh.-based personalized medicine company that specializes in pharmacogenomics, has raised $15 million in Series D extension funding from existing (unnamed) investors

4Tech, a six-year-old, Newton, Ma.-based medical device company focused on the treatment of tricuspid valve disease, has raised $26.4 million, shows an SEC filing. The company had previously raised at least $7 million previously

Mobile fitness app MobieFit received US$1 million in investment from Medi Assist India. Medi Assist India is a healthcare services provider that deals in medical insurance

Healthcare consultation startup Doctor Insta announced its pre-series A funding totaling US$500,000 from angel investor Rishi Parti and BrahmaX Ventures, a US-based venture capital firm

PurelyB, an all-women Malaysia-based startup that today announced a US$500,000 seed round (roughly RM 2.1 million), seeks to make a difference in this area

PE Deals (7 Deals)

FastMed Urgent Care, a Gilbert, Ariz.-based urgent care organization sponsored by ABRY Partners, has acquiredTexan Urgent Care, a 14-clinic urgent care operator in Texas. No financial terms were disclosedPE Deals

Grupo Biotoscana SL, a Latin American pharma company backed by Advent International and Essex Woodlands Health Ventures, has acquiredLaboratorio LKM SA, an Argentina-based specialty pharmaceutical manufacturer that also was controlled by Advent International. No financial terms were disclosed. The combined company is expected to generate annual revenue of around $250 million

 New Mountain Capital has acquired (and will merge)Equian, an Indianapolis-based provider of healthcare payment integrity solutions to medical claim payors, andTrover Solutions, a Louisville, Ky.-based provider of cost containment services and software to the private healthcare payer and property & casualty industries. Equian is being purchased for $225 million, and previously was a portfolio company of Great Point Partners. No financial terms for Trover Solutions, which is being sold by ABRY Partners and Veronis Suhler Stevenson

Schryver Medical Sales and Marketing LLC, a Denver-based portfolio company of Revelstoke Capital Partners, has acquired two companies:Community Portable X-Ray Inc., a Plano, Texas-based provider of mobile x‐ray and other imaging services; and MetroStat, a Garland, Texas-based provider of clinical laboratory services and mobile imaging services. No financial terms were disclosed for either purchase

Varsity Healthcare Partners has sponsored a recapitalization of Colonial Family Practice, a provider of primary care and ancillary patient diagnostic services in South Carolina. No financial terms were disclosed

Vertice Pharma LLC, a branded and generics pharma acquisition platform recently formed via a $300 million equity commitment from Warburg Pincus, has completed its previously-announced acquisition of VistaPharm, a Birmingham, Ala.-based generics manufacturer of liquid and unit dosage pain medications. No financial terms were disclosed

Precision for Medicine Inc., a Chevy Chase, Md.-based provider of services for drug development and commercialization, has secured $75 million in growth equity funding from TPG Growth

IPO Deals (2 Deals)

Cancer Prevention Pharmaceuticals Inc., a Tucson, Ariz.-based developer of therapeutics for the treatment and prevention of certain pre-cancerous conditions, has filed for a $28.75 million IPO. It plans to trade on the NYSE MK, with Aegis Capital serving as sole underwriter

Proteostasis Therapeutics Inc., a Cambridge, Mass.-based developer of therapeutics to treat diseases caused by defects in protein processing, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol PTI, with Leerink Partners and RBC Capital Markets serving as lead underwriters. The pre-revenue company has raised over $50 million in VC funding, from firms like Elan Science One (21.6% pre-IPO stake), New Enterprise Associates (17.1%), Healthcare Ventures (13.9%), Fidelity Biosciences (11.7%), Novartis Bioventures (11.6%), Sanofi-Genzyme BioVentures (5.8%) and Cormorant Asset Management

Other Deals (1 Deal)

PharmMerica Corp. (NYSE: PMC) has made two acquisitions: Integrated Pharmacy Network, a Midland, Mich.-based long-term care pharmacy; andAlternacare Infusion Pharmacy, an Olathe, Kan.-based provider of specialty home infusion services. No financial terms were disclosed for either deal

Sources: Term Sheet, Financial Times, StrictlyVC, TechinAsia, CrunchBase, TechCrunch, Bloomberg

The Propell Group

#healthtech #asia